drugset / Trial / NCT02146209

Study to Determine the Equivalence of Three Products Containing Metronidazole Benzoate.

NCT02146209

Phase 1 Completed 6 enrolled Verisfield UK Ltd. Greek Branch
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to determine whether Terix Labs Ltd Metronidazole benzoate (400 mg Metronidazole Per Sachet Oral Granules) is bioequivalent to 500 mg Sanofi-aventis Flagyl 125 mg/5 ml (125 mg Metronidazole Per 5 ml Suspension) and to Zentiva Flagyl™ 400 mg Tablets (400 mg Metronidazole Per Film Coated Tablets).

Timeline

Start
2014-06
Primary completion
2014-06
Completion
2014-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Metronidazole Small molecule 400 mg Oral
Subject Metronidazole Small molecule 500 mg Oral